Fig. 3From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancerThe expression of SMARCAs between pancreatic cancer tissues and normal tissues (GEPIA). A The transcripts per million (TPM) levels of SMARCAs between pancreatic cancer tissues and normal tissues; B The mRNA levels of SMARCAs between pancreatic cancer tissues and normal tissuesBack to article page